A CDC advisory panel is set to convene an emergency meeting next week to discuss heartburn reports of adolescents who have received the COVID-19 vaccine.
The CDC says 226 confirmed cases of the condition, called myocarditis, have been reported in people under 30 who have received the Pfizer or Moderna COVID-19 vaccine.
Myocarditis tends to be temporary and clears up with treatment and monitoring, but the CDC is analyzing these cases to see if there’s a link to vaccination.
Dr. Tom Shimabukuro of the CDC’s Immunization Safety Office said there’s an “imbalance” in the number of cases but told an FDA advisory committee more details still need to be confirmed.
“The observed reports are exceeding the expected — based on the background, the known background rates that are published in the literature,” he told an FDA advisory committee this week.
“It’s a bit of an apples to oranges comparison, because again, these are preliminary reports. Not all of these will turn out to be true myocarditis or pericarditis reports,” he added.
More than 800 unsupported cases of heart problems have been reported to the Vaccine Safety Monitoring System, but the CDC says most are concerned about people under the age of 30. The agency said it has seen myocarditis and inflammation of the heart membranes higher than normal. The CDC Advisory Committee meeting with 226 confirmed cases will receive an update on those reports at next week.
Although side effects are still considered rare out of the millions of people who have been vaccinated, the number is higher than the amount of people expected to develop the condition in the general population, which is why organizations and outside experts are looking closely. Determining if there may be a connection with the vaccine.
Independent experts that the CDC and FDA consult are considering questions about the risks and benefits available for vaccination kids. They want to make sure that just as the country wants more vaccines for the population to reach pastoral immunity, there will be enough data to ensure that vaccine benefits outweigh any potential side effects.
Conversations and ongoing research COVID-19 contracted, including any illness called MIS-C, will balance the risk of children from the possibility of more serious side effects from the vaccine.